TD Asset Management Inc Sells 26,544 Shares of Agilent Technologies, Inc. $A

Key Points

• TD Asset Management reduced its Agilent Technologies stake by 2.6%, selling 26,544 shares during the second quarter and retaining 996,884 shares valued at approximately $132.4 million. Institutional investors collectively own 87.41% of the company.
• Analysts maintain a positive outlook, with Agilent carrying a consensus “Moderate Buy” rating and an average price target of $160.24. Recent targets range from $135 to $156.
• Agilent reported quarterly EPS of $1.49, exceeding estimates by $0.08, while revenue rose 10% year over year to $1.83 billion. The company also pays a quarterly dividend of $0.255 per share, representing a 0.7% yield.

TD Asset Management Inc trimmed its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 2.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 996,884 shares of the medical research company's stock after selling 26,544 shares during the quarter. TD Asset Management Inc owned 0.35% of Agilent Technologies worth $132,416,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of A. Fiduciary Trust Co increased its position in Agilent Technologies by 1.6% during the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company's stock worth $633,000 after acquiring an additional 77 shares during the period. Sapient Capital LLC raised its stake in Agilent Technologies by 4.2% during the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company's stock valued at $240,000 after purchasing an additional 85 shares during the last quarter. Plan A Wealth LLC boosted its holdings in Agilent Technologies by 3.2% in the 4th quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company's stock valued at $403,000 after purchasing an additional 92 shares during the period. IHT Wealth Management LLC boosted its holdings in Agilent Technologies by 4.9% in the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company's stock valued at $278,000 after purchasing an additional 96 shares during the period. Finally, KPP Advisory Services LLC grew its position in Agilent Technologies by 2.4% in the 2nd quarter. KPP Advisory Services LLC now owns 4,382 shares of the medical research company's stock worth $582,000 after purchasing an additional 103 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on A shares. Jefferies Financial Group initiated coverage on shares of Agilent Technologies in a report on Thursday, July 9th. They set a "hold" rating and a $135.00 price objective on the stock. Weiss Ratings upgraded shares of Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, June 2nd. Wolfe Research reissued a "hold" rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Barclays lifted their target price on Agilent Technologies from $145.00 to $150.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 24th. Finally, Robert W. Baird upped their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a report on Tuesday, May 26th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of "Moderate Buy" and a consensus target price of $160.24.

Agilent Technologies Trading Down 0.5%

Shares of A opened at $148.55 on Friday. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock has a 50 day simple moving average of $135.38 and a 200-day simple moving average of $125.56. The stock has a market cap of $41.96 billion, a PE ratio of 29.83, a PEG ratio of 2.64 and a beta of 1.25.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.During the same quarter in the previous year, the firm earned $1.31 EPS. Agilent Technologies's quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were issued a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies's dividend payout ratio (DPR) is presently 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source